Suggested for -nE:
AHUSD - Overview: Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma
Detecting deficiencies in the alternative pathway that can cause atypical-hemolytic uremic syndrome, dense deposit disease, and C3 glomerulonephritis A second-tier test that aids in the differential diagnosis of thrombotic...
SALCT - Overview: Cortisol, Saliva
Screening for Cushing syndrome Diagnosis of Cushing syndrome in patients presenting with symptoms or signs suggestive of the disease
SFX - Overview: Protein S Activity, Plasma
Second-order testing for diagnosis of congenital or acquired protein S deficiency, ie, as an adjunct to initial testing based on results of protein S antigen assay (free protein S antigen, with or without total protein S antigen assay)...
Identifying class I and II human leukocyte antigens (HLA) for potential disease associations or markers for drug hypersensitivity
CTB - Overview: Mycobacteria and Nocardia Culture, Varies
Detection and identification of Mycobacterium species, Nocardia species, and other aerobic actinomycetes
LIPA1 - Overview: Lipoprotein(a), Serum
Cardiovascular disease (CVD) risk refinement in patients with moderate or high risk based on conventional risk factors or patients with clinical suspicion of residual CV risk not identified by other lipid parameters
OPE - Overview: Ova and Parasite, Travel History or Immunocompromised, Feces
Detecting and identifying parasitic protozoa and eggs and larvae of parasitic helminths in stool specimens
FIFLC - Overview: Immunofixation with Free Light Chains, Quantitative, Urine
Immunofixation with Free Light Chains, Quantitative, Urine
MUSK - Overview: Muscle-Specific Kinase (MuSK) Autoantibody, Serum
Diagnosis of autoimmune muscle-specific kinase (MuSK) myasthenia gravis Second-order test to aid in the diagnosis of autoimmune myasthenia gravis when first-line serologic tests are negative Establishing a quantitative baseline value...
REVE2 - Overview: Erythrocytosis Evaluation, Blood
Definitive, comprehensive, and economic evaluation of an individual with JAK2-negative erythrocytosis associated with lifelong sustained increased hemoglobin or hematocrit